東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Transcription Factor MEF2A Fine-Tune...

Medrano, Jose Luis.

FindBook

Google Book

Amazon

博客來

Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart./
作者:	Medrano, Jose Luis.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	185 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-04, Section: B.
Contained By:	Dissertations Abstracts International80-04B.
標題:	Molecular biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10688264
ISBN:	9780438569928

Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart.
Medrano, Jose Luis.

Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 185 p.

Source: Dissertations Abstracts International, Volume: 80-04, Section: B.

Thesis (Ph.D.)--Boston University, 2018.

This item must not be sold to any third party vendors.

The distinct morphological and functional properties of mammalian heart chambers arise from an elaborate developmental program involving cell lineage determination, morphogenesis, and dynamic spatiotemporal gene expression patterns. While a number of transcription factors have been identified for proper gene regulation in the chambers, the complete transcriptional network that controls these patterns remains poorly defined. Previous studies have implicated MEF2 transcription factors in the regulation of chamber-restricted enhancers. To better understand the mechanisms of MEF2-mediated regional gene regulation in the heart, MEF2A knockout (KO) mice, a model that displays a predominantly ventricular chamber phenotype, are used herein. Transcriptomic analysis of atrial and ventricular tissue from adult MEF2A KO hearts revealed extensive differences in chamber gene expression across the heart, with a larger proportion of dysregulated genes in atrial chambers. Thus, it is hypothesized that MEF2A differentially regulates expression of target genes and cellular pathways in cardiac chambers. Functional pathway analysis of genes preferentially dysregulated in the atria and ventricles supported this hypothesis and revealed distinct MEF2A-dependent cellular processes in each cardiac chamber. In atria, MEF2A regulated the expression of genes involved in fibrosis and adhesion, whereas in ventricles, it controlled genes involved in inflammation and endocytosis. Additional studies uncovered preferential dysregulation of molecular components of these pathways in MEF2A KO hearts. Phosphorylated focal adhesion kinase (FAK) levels, relating to cell adhesion, were preferentially downregulated in KO atria, and TRAF6 proteins levels, relating to inflammation, were preferentially downregulated in KO ventricles. Finally, analysis of transcription factor binding site motifs of differentially dysregulated genes uncovered distinct MEF2A coregulators for the atrial and ventricular gene sets. A subset of these transcriptional coregulators were found to cooperate with MEF2A to activate MEF2-dependent reporters in vitro. In conclusion, these results suggest a mechanism in which MEF2 transcriptional activity is differentially recruited to fine-tune gene expression levels in each cardiac chamber. This regulatory mechanism ensures the optimal output of gene products for proper physiological function of the atrial and ventricular chambers. Lastly, one of the preferentially dysregulated genes, Bex1, was further characterized. Future studies will focus on the role of MEF2A-regulated Bex1 in the adult heart.

ISBN: 9780438569928Subjects--Topical Terms:

517296
Molecular biology.

Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart.
LDR:03742nmm a2200337 4500 001 2210266
005 20191121124155.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780438569928
035 $a (MiAaPQ)AAI10688264
035 $a (MiAaPQ)bu:13497
035 $a AAI10688264
040 $a MiAaPQ $c MiAaPQ
100 1 $a Medrano, Jose Luis. $3 3437410
245 1 0 $a Transcription Factor MEF2A Fine-Tunes Gene Expression in the Atrial and Ventricular Chambers of the Adult Mouse Heart.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 185 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-04, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Naya, Francisco J.
502 $a Thesis (Ph.D.)--Boston University, 2018.
506 $a This item must not be sold to any third party vendors.
520 $a The distinct morphological and functional properties of mammalian heart chambers arise from an elaborate developmental program involving cell lineage determination, morphogenesis, and dynamic spatiotemporal gene expression patterns. While a number of transcription factors have been identified for proper gene regulation in the chambers, the complete transcriptional network that controls these patterns remains poorly defined. Previous studies have implicated MEF2 transcription factors in the regulation of chamber-restricted enhancers. To better understand the mechanisms of MEF2-mediated regional gene regulation in the heart, MEF2A knockout (KO) mice, a model that displays a predominantly ventricular chamber phenotype, are used herein. Transcriptomic analysis of atrial and ventricular tissue from adult MEF2A KO hearts revealed extensive differences in chamber gene expression across the heart, with a larger proportion of dysregulated genes in atrial chambers. Thus, it is hypothesized that MEF2A differentially regulates expression of target genes and cellular pathways in cardiac chambers. Functional pathway analysis of genes preferentially dysregulated in the atria and ventricles supported this hypothesis and revealed distinct MEF2A-dependent cellular processes in each cardiac chamber. In atria, MEF2A regulated the expression of genes involved in fibrosis and adhesion, whereas in ventricles, it controlled genes involved in inflammation and endocytosis. Additional studies uncovered preferential dysregulation of molecular components of these pathways in MEF2A KO hearts. Phosphorylated focal adhesion kinase (FAK) levels, relating to cell adhesion, were preferentially downregulated in KO atria, and TRAF6 proteins levels, relating to inflammation, were preferentially downregulated in KO ventricles. Finally, analysis of transcription factor binding site motifs of differentially dysregulated genes uncovered distinct MEF2A coregulators for the atrial and ventricular gene sets. A subset of these transcriptional coregulators were found to cooperate with MEF2A to activate MEF2-dependent reporters in vitro. In conclusion, these results suggest a mechanism in which MEF2 transcriptional activity is differentially recruited to fine-tune gene expression levels in each cardiac chamber. This regulatory mechanism ensures the optimal output of gene products for proper physiological function of the atrial and ventricular chambers. Lastly, one of the preferentially dysregulated genes, Bex1, was further characterized. Future studies will focus on the role of MEF2A-regulated Bex1 in the adult heart.
590 $a School code: 0017.
650 4 $a Molecular biology. $3 517296
650 4 $a Cellular biology. $3 3172791
650 4 $a Biochemistry. $3 518028
690 $a 0307
690 $a 0379
690 $a 0487
710 2 $a Boston University. $b Molecular Biology, Cell Biology & Biochemistry GRS. $3 3437411
773 0 $t Dissertations Abstracts International $g 80-04B.
790 $a 0017
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10688264